Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 20.90M | $ 46.80M | $ 43.20M | $ 38.20M | $ 19.60M |
Total Assets | $ 2.71B | $ 2.50B | $ 2.12B | $ 1.86B | $ 1.70B |
Total Debt | $ 719.20M | $ 707.10M | $ 567.00M | $ 543.30M | $ 531.70M |
Net Debt | $ 698.30M | $ 660.30M | $ 523.80M | $ 505.10M | $ 512.10M |
Total Liabilities | $ 914.10M | $ 889.40M | $ 742.40M | $ 690.70M | $ 665.50M |
Stockholders Equity | $ 1.79B | $ 1.61B | $ 1.37B | $ 1.17B | $ 1.04B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |